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Case Report
Abstract
Germ cell tumors are unusual, but they represent the most common neoplasm in young men. Since the introduction of
cisplatin-based chemotherapy, most cases are expected to be cured today. Intensive monitoring of these patients during fol-
low-up is required to rule out relapses or late complications of therapy. We present the case of a 21-year-old male who devel-
oped extensive lung dissemination by Langerhans cell histiocytosis eight months after the successful treatment of a bulky
mediastinal seminoma.
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Introduction
Germ cell tumors represent the most common neoplasm in
young men. They constitute the model of a curable neoplasm.
The combination of surgery and cisplatin-based chemother-
apy allows the cure of most patients, even with advanced
disease at diagnosis.1 Most cases have a primary testicular
location but a proportion of them appear in midline
extragonadal sites such as pineal gland, mediastinum or
retroperitoneum.
Mediastinal germ cell tumors share a worse prognosis than
their testicular counterparts. However, extragonadal semi-
nomas have a better behavior than mediastinal non-semin-
omas.2 Lung metastases are common in advanced testicular
cancer. The synchronicity of two uncommon diseases such as
germ cell tumors and langerhans cell histiocytosis (LCH) is
exceptionally unusual, and so a precise differential diagnosis
with other pathologies is needed to allow a specific treatment.
Case report
We report the case of a 21-year-old male, with no relevant
medical history but a smoking habit of 2.5 pack/year. He did
not suffer from inguinal hernia nor had history of cryptor-
chidism.
The patient related a severe chest pain and the loss of 4 kg of
weight during the six previous months without any apparent
cause. Moreover, he showed severe asthenia and uncertain
effort dyspnea. In April 2012, a CT scan of chest, abdomen
and pelvis with intravenous contrast was done. The conclu-
sion was: anterior mediastinal mass with infiltration of me-
diastinum, great vessels, anterior tracheal wall, pericardium
and left atrium. No any distant lesions. Differential diagnosis
by image was between lymphoma and malignant germ cell
tumor (Figure 1).
FIG. 1: Thoracic CT Diagnosis. Locally advanced mass in the anterior
mediastinum
On physical examination, the only finding was a cervical
edema and collateral circulation in the front of the chest.
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Normal blood tests results except lactate dehydrogenase
(821U/L), beta subunit of the gonadotropic hormone
(41.8mU/ml); fibrinogen of 672 mg/dl and erythrocyte sedi-
mentation rate (ESR) of 54 mm/h. The alpha-fetoprotein
(AFP) was 1.3 ng/mL.
The definitive diagnosis confirmed by histopathology was
pure extragonadal seminoma with cell proliferation index
(Ki-67) 70%. Therefore, the treatment chosen was four cycles
of BEP chemotherapy (bleomycin, etoposide, cisplatin) with
primary prophylaxis of neutropenia support. The intent of
treatment was curative. We requested as part of the initial
study, viral serology and the preservation of fertility before
the treatment was performed.
The clinical tolerance of treatment was acceptable, presenting
only grade 2-3 emesis, which was controlled with standard
antiemetic therapy. No dose reduction or delay was needed.
Disease evaluation after four cycles of BEP showed a partial
radiological response, with normalization of tumor markers
after the first cycle. A positron emission tomography
(PET-CT) showed absence of metabolic activity (complete
response), so closely follow-up was decided.
The CT evaluation after six months showed further volume
regression of the disease with residual mediastinal mass of 25
× 38 mm (Figure 2).
FIG. 2: Thoracic CT Evaluation. Residual mediastinal mass with
internal calcifications.
During the monitoring, in the CT of March 2013 (eight
months after ending the chemotherapy) multiple and bilat-
eral cavitary lung lesions appeared with signs of rapid growth
(Figure 3). PET-CT confirmed these findings and informed of
an abnormal metabolism in a lymph node of the right hilum,
suggesting a metastatic affectation.
FIG. 3: Monitoring thoracic CT. Bilateral, multiple cavitary lung
lesions.
The patient remained asymptomatic and the rest of the com-
plementary tests were normal including tumor markers. A
pathological and microbiological study of the lung lesions was
performed in April 2013.The definitive diagnosis was Lang-
erhans cell histiocytosis in cellular stage and respiratory
bronchiolitis (Figure 4).
FIG.4: Histopathological and immunohistochemical diagnosis: (A)
Dense infiltrates composed mainly of Langerhans cells mixed with
occasional eosinophils and lymphocytes (HE, 200x): (B) Intense and
diffuse cytoplasmatic positive staining with pS-100 (ps-100, 200x):
(C) Intense and diffuse positive staining with Langerin (Langerin,
200x): (D) Intense and diffuse positive staining with CD1-a (CD1-a,
200x).
As Langerhans cell histiocytosis was located exclusively in
the lung, without any clinical impact, we decided to closely
monitor the patient with the strict recommendation of to-
bacco cessation. At this moment, a year and eight months
after ending the chemotherapy, the patient continues with
follow-up, he remains asymptomatic, and living in a normal
lifestyle.
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Discussion
Germ cell tumors, although considered an unusual tumor, are
the most common neoplasm in males aged 15-35 years old
(1% of all cancers approximately). The treatment of this dis-
ease has experienced considerable advances in the last dec-
ades and has demarcated in a more precise way the patients
that need treatment, as well as their therapy. This partially
explains the significant increase in these patients’ survival.3
The young age, the high curability of this neoplasm and, as in
our case, the chemotherapy treatment employed make ex-
tremely important a long term monitoring of these patients.
The objectives of this follow-up are the early detection of
local or distant recurrences and the early diagnosis of even-
tual second tumors.4 During the two first years, the moni-
toring has to be closer because the probability of a tumor
relapse is higher. In the case we present, the lung image al-
teration (bilateral, cavitary nodules) prompted us to rule out
metastatic disease. Other possibilities to keep in mind are the
infectious causes and the pulmonary toxicity by bleomycin,
in which there is no rising of tumor markers, like in our
patient. Contrary to this last possibility was its subpleural
localization of a typical shape and its appearance in a short
period of time after the chemotherapy administration.5
LCH is a disease with unknown incidence and prevalence.
Etiological or other risk factors have not been described yet,
but it has been noticed that most patients diagnosed with lung
involvement (generally young men) smoke, that is why it is
believed that smoking has an important role in the develop-
ment of the disease.6
It can affect only one organ, such as the lung, or it can be
more severe in the multi-systemic forms. In the exclusively
lung form, symptomatic patients can present dyspnea, chest
pain (usually secondary to pneumothorax) and other respir-
atory symptoms. In many patients it is asymptomatic, espe-
cially in early stages of the disease. In this stage, like in our
case, the secondary lesions of LCH have an increased SUV in
PET, and it can suggest other neoplastic disease.7
LCH is an eosinophilic granulomatous disease, with a certain
similarity to sarcoidosis in its radiological, clinical and histo-
logical appearance. The cases described in the literature of
association between LCH and seminomas are extraordinary.
However, the association between germ tumor and
sarcoidosis is slightly more frequent.8
Although LCH has an unpredictable course and requires a
close monitoring, the chest disease usually has a good evolu-
tion and sometimes it has a spontaneous healing. The first
treatment step in smoking patients is to stop this habit. If this
measure is not enough to attain the complete remission of the
disease, other approaches can be required, such as the ad-
ministration of corticosteroids.9
Conclusion
Our case is an example of an unusual medical situation be-
cause both extragonadal seminoma and LCH diagnosis are
exceptional. It illustrates the difficulties to carry out an ap-
propriate differential diagnosis and a correct management of
these types of pathologies.
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